A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

THURSDAY, Jan. 30, 2025 (HealthDay News) -- For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy. If left untreated, approximately one-third of these cases progress to cervical ...

Use your voice to deepen the dialogue and engage with stories of courage, endurance, community, triumph, and the pursuit of truth in SA.

Squamous cell carcinoma is the most common type of cervical cancer. The altered squamous cells can be detected with a Pap smear and the presence of dysplasia or cancer can be confirmed with a biopsy.

The proportions of women with CIN 2+ and CIN 3+ on excisional procedure within 24 months of CIN 1 cervical biopsy were calculated with binomial exact CIs.

Emily Fukuchi, MD; Barbara Fetterman, SCT (ASCP); Nancy Poitras, ACS, PMP; Walter Kinney, MD; Thomas Lorey, MD; Ramey D. Littell, MD To evaluate whether the presence of CIN 1 on ECC contributes to ...

A knowledge gap around cervical screenings is currently "costing lives", a cancer charity says. The Eve Appeal says more women need to know they can ask for adjustments to their cervical ...